In search for better pharmacological prophylaxis for acute mountain sickness: looking in other directions

Acta Physiologica
Hui LuZ P Jia

Abstract

Despite decades of research, the exact pathogenic mechanisms underlying acute mountain sickness (AMS) are still poorly understood. This fact frustrates the search for novel pharmacological prophylaxis for AMS. The prevailing view is that AMS results from an insufficient physiological response to hypoxia and that prophylaxis should aim at stimulating the response. Starting off from the opposite hypothesis that AMS may be caused by an initial excessive response to hypoxia, we suggest that directly or indirectly blunting-specific parts of the response might provide promising research alternatives. This reasoning is based on the observations that (i) humans, once acclimatized, can climb Mt Everest experiencing arterial partial oxygen pressures (PaO2) as low as 25 mmHg without AMS symptoms; (ii) paradoxically, AMS usually develops at much higher PaO2 levels; and (iii) several biomarkers, suggesting initial activation of specific pathways at such PaO2, are correlated with AMS. Apart from looking for substances that stimulate certain hypoxia triggered effects, such as the ventilatory response to hypoxia, we suggest to also investigate pharmacological means aiming at blunting certain other specific hypoxia-activated pathways, or stimul...Continue Reading

References

Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·G L SemenzaS E Antonarakis
Nov 1, 1970·Archives of Environmental Health·J E Hansen, W O Evans
Sep 1, 1983·Thorax·J S Milledge
Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·G L WangG L Semenza
Apr 15, 1993·Annals of Internal Medicine·B HonigmanP Pearce
Sep 1, 1996·Molecular and Cellular Biology·J A ForsytheG L Semenza
May 9, 1998·Journal of Applied Physiology·R S MazzeoL G Moore
Jun 16, 1999·Nitric Oxide : Biology and Chemistry·I Y MalyshevA F Vanin
Feb 5, 2000·Journal of Applied Physiology·R C RoachJ A Loeppky
Oct 12, 2000·Journal of Cardiovascular Pharmacology·H ChenK Shimada
Mar 17, 2001·High Altitude Medicine & Biology·D M Bailey, B Davies
Jul 14, 2001·The New England Journal of Medicine·P H Hackett, R C Roach
Feb 2, 2002·Science·David LandoMurray L Whitelaw
Oct 23, 2002·Brain : a Journal of Neurology·Heike J SchochHugo H Marti
Dec 10, 2002·Medicine and Science in Sports and Exercise·Michael SchneiderPeter Bartsch
Dec 20, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Katja IssbrückerMatthias Clauss
Dec 23, 2003·Cephalalgia : an International Journal of Headache·R FischerR M Huber
Apr 6, 2004·Methods in Enzymology·Nanduri R PrabhakarGanesh K Kumar
May 28, 2004·Emergency Medicine Clinics of North America·Scott A Gallagher, Peter H Hackett
Oct 27, 2004·Journal of Applied Physiology·Jack A LoeppkyRobert C Roach
Jan 15, 2005·Journal of Applied Physiology·Martha C Tissot van PatotPeter Hackett
Feb 5, 2005·Stroke; a Journal of Cerebral Circulation·Aurélie Van OstaRobert Naeije
Jun 17, 2005·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Damian M BaileyPeter Bärtsch
Aug 2, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Paola A LanfranchiPantaleo Giannuzzi
Jan 7, 2006·The Journal of Physiology·Russell S RichardsonPierre G Carlier
Oct 28, 2006·Journal of Applied Physiology·Michael Y SongLouis G D'Alecy
Sep 11, 2007·High Altitude Medicine & Biology·Robert Roach, Bengt Kayser
Nov 14, 2007·Methods in Enzymology·Wolfgang Jelkmann
Nov 13, 2008·Aviation, Space, and Environmental Medicine·Yunden DromaKeishi Kubo
Jan 9, 2009·The New England Journal of Medicine·Michael P W GrocottUNKNOWN Caudwell Xtreme Everest Research Group
Jan 24, 2009·Lancet Neurology·Mark H WilsonChris H Imray
Mar 11, 2009·QJM : Monthly Journal of the Association of Physicians·J K BaillieD J Webb
Apr 22, 2009·Aviation, Space, and Environmental Medicine·Gary H KamimoriHarry Q Davis

❮ Previous
Next ❯

Citations

May 13, 2017·Acta Physiologica·P B Persson, A Bondke Persson
Jun 13, 2019·Current Pharmaceutical Design·Yidan DingXuechun Yuan
Jan 30, 2016·Acta Physiologica·S Dietze, A Patzak
Jun 15, 2017·Frontiers in Immunology·Bao LiuYuqi Gao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.